What should we advise about adjunctive therapies, including herbal medicines, for hepatitis C?
- 1 May 2000
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 15 (5 (Suppl.)) , E164-E171
- https://doi.org/10.1046/j.1440-1746.2000.02117.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Characteristics of best gastroenterology practicesAmerican Journal of Gastroenterology, 1999
- Health-related quality of life in chronic hepatitis C: Impact of disease and treatment responseHepatology, 1999
- A pilot study of iron depletion as adjuvant therapy in chronic hepatitis C patients not responding to interferonAmerican Journal of Gastroenterology, 1999
- Lactoferrin Inhibits Hepatitis C Virus Viremia in Patients with Chronic Hepatitis C: A Pilot StudyJapanese Journal of Cancer Research, 1999
- A pilot randomized, controlled trial of the effect of iron depletion on long-term response to α-interferon in patients with chronic hepatitis CJournal of Hepatology, 1998
- Treatment of Chronic Hepatitis C With Interferon With or Without Ursodeoxycholic AcidJournal of Clinical Gastroenterology, 1998
- Iron stores, response to α‐interferon therapy, and effects of iron depletion in chronic hepatitis CLiver International, 1996
- Efficacy of ursodeoxycholic acid therapy in chronic viral hepatitis C with high serum ?-glutamyltranspeptidase levelsThe Esophagus, 1996
- Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis CJournal of Hepatology, 1995
- A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis CHepatology, 1994